PCSK9 inhibition is an upcoming therapeutic target for patients with hypercholesterolemia and due to the high coincidence of heart failure in this population, it is important to understand the role of oxLDL, LOX-1, and PCSK9 in cardiomyocytes. The gene discussed is PCSK9; the disease is Hypercholesterolemia.